In contrast to the moderate phenotypes in adult Atp2a2 knockout mice, CASAAV-based Atp2a2 knockout in neonates resulted in acute dilated cardiomyopathy and death within 3 weeks after AAV administration. Here, ATP2A2 is linked to dilated cardiomyopathy.